Lung Abscess

A lung abscess is a localized collection of pus within an area of destroyed lung parenchyma, forming a thick-walled, necrotic cavity. The condition is life-threatening if untreated yet highly curable with the right antibiotic selection and adequate drainage. Most cases arise from aspiration of oropharyngeal bacteria in people with altered consciousness or poor dentition, and anaerobes dominate the microbiology. Understanding the distinction between primary and secondary lung abscess — and identifying the causative organism — is essential for directing treatment and predicting outcome.

Table of Contents

1. Primary vs. Secondary Lung Abscess
2. Risk Factors for Aspiration
3. Microbiology
4. Pathophysiology and Location
5. Symptoms and Clinical Presentation
6. Diagnosis: Imaging and Laboratory
7. Antibiotic Treatment
8. Drainage and Surgical Intervention
9. Outcomes and Complications
10. References & Research
11. Featured Videos

Primary vs. Secondary Lung Abscess

The first and most clinically important distinction is whether the abscess arises in otherwise normal lung (primary) or as a complication of an underlying structural or systemic problem (secondary). This classification shapes the diagnostic workup, the expected microbiology, and the likelihood of cure with antibiotics alone.

Primary Lung Abscess

Primary lung abscess accounts for approximately 65% of cases and is almost always caused by aspiration of infected oropharyngeal material into the lung in a susceptible host. Because the host's normal lung architecture was intact before the event, the abscess is the only lesion and the surrounding lung is otherwise healthy. Response to antibiotics alone is excellent — approximately 85–90% of primary abscesses resolve without invasive intervention.

Secondary Lung Abscess

Secondary lung abscess occurs as a consequence of an identifiable underlying cause that sets the stage for infection. The major categories include:

• Post-obstructive: Endobronchial obstruction by a tumor (primary lung cancer is the most important), foreign body, or enlarged lymph node prevents clearance of secretions distal to the obstruction. This stagnant pool becomes infected, forming an abscess. Any lung abscess in a middle-aged or older patient without clear aspiration risk factors must prompt bronchoscopy to exclude an obstructing lesion.
• Hematogenous seeding: Bacteremic seeding of the lungs from a distant focus, classically right-sided bacterial endocarditis (tricuspid or pulmonary valve) or septic thrombophlebitis — particularly in people who inject drugs. The classic organism is Staphylococcus aureus. Hematogenous abscesses are characteristically multiple, bilateral, and distributed throughout the lung fields rather than confined to dependent segments.
• Direct spread: Extension from a subphrenic abscess, liver abscess (via diaphragm), or mediastinal infection into the adjacent lung parenchyma. Also includes post-traumatic necrosis and infected pulmonary infarcts.
• Immunocompromised host: Patients with HIV/AIDS, transplant recipients, or those on prolonged corticosteroids are susceptible to opportunistic organisms that rarely cause abscesses in immunocompetent people — including Nocardia, fungi (Aspergillus), and mycobacteria.

Risk Factors for Aspiration

Because the majority of lung abscesses arise from aspiration, recognizing the circumstances that impair the normal oropharyngeal defense against aspiration is foundational. The aspiration events that lead to lung abscess are typically silent — small-volume microaspirations of oropharyngeal secretions during sleep, not dramatic witnessed large-volume events. It is the combination of bacterial load in the oropharynx (primarily from dental disease), impaired cough reflex, and impaired consciousness that allows organisms to reach the distal airways in sufficient numbers to establish infection.

Major Aspiration Risk Factors

• Alcoholism and alcohol intoxication: The most common risk factor. Alcohol suppresses the cough and gag reflexes and is associated with poor dentition (higher oropharyngeal bacterial burden) and prolonged recumbency. The combination makes aspiration pneumonia and abscess formation far more likely.
• Altered level of consciousness: General anesthesia, drug overdose, head trauma, stroke, and seizure disorders all impair the protective airway reflexes. Postictal states after seizures are a classic and underappreciated risk period for silent aspiration.
• Dysphagia: Neurological causes (Parkinson's disease, multiple sclerosis, post-stroke bulbar palsy, ALS) and structural causes (esophageal strictures, Zenker's diverticulum, esophageal cancer) impair the coordination of swallowing and increase aspiration risk dramatically. Oropharyngeal dysphagia — difficulty initiating the swallow — carries higher aspiration risk than esophageal dysphagia.
• Poor dentition and periodontal disease: A high bacterial load in the mouth, particularly high concentrations of anaerobes, means that even small-volume aspirations deliver a large inoculum of pathogenic organisms to the lung. Patients who are edentulous have substantially lower rates of aspiration pneumonia and lung abscess because total oral bacterial burden is reduced.
• GERD and achalasia: Gastroesophageal reflux disease permits gastric contents (acidic fluid plus any colonizing bacteria) to reach the pharynx. Achalasia causes pooling of food and liquid in a dilated esophagus that overflows into the pharynx, especially at night.
• Immunosuppression: While not primarily increasing aspiration risk, immunosuppression allows bacteria that would normally be cleared after small aspirations to establish infection in the lung.

Microbiology

The bacteriology of lung abscess is fundamentally driven by the mechanism of formation, and the distinction between aspiration-primary and non-aspiration causes is decisive.

Anaerobes: The Dominant Organisms in Aspiration Abscess

Mixed anaerobic bacteria from the oropharyngeal flora are the predominant cause of primary (aspiration-related) lung abscesses. The oropharynx harbors enormous concentrations of anaerobes — up to 10⁸ organisms per mL of saliva — so even small aspirations deliver large numbers. The major culprits include:

• Bacteroides species (particularly Bacteroides melaninogenicus, now reclassified as Prevotella melaninogenica)
• Fusobacterium nucleatum — commonly recovered, highly virulent
• Prevotella species — gram-negative anaerobic rods from the oral flora
• Peptostreptococcus species — anaerobic gram-positive cocci

Cultures of expectorated sputum are generally unreliable for anaerobes because the specimen is invariably contaminated by oropharyngeal flora containing the same organisms. Reliable anaerobic cultures require bronchoscopic protected specimen brush sampling, transtracheal aspiration, or percutaneous needle aspiration — procedures not routinely required when the clinical picture is classic for aspiration abscess. In practice, most primary anaerobic abscesses are treated empirically based on clinical diagnosis.

Aerobic and Facultative Organisms

• Klebsiella pneumoniae: Has a special association with lung abscess in alcoholic men, historically described with "currant jelly" sputum (blood-tinged, gelatinous, from the mucoid capsule), and a predilection for the posterior segment of the upper lobe or superior segment of the lower lobe. Klebsiella abscesses tend to be rapidly destructive, often creating large cavities with surrounding pneumonia and can extend into the pleural space. The classic Friedlander's pneumonia pattern.
• Staphylococcus aureus (including MRSA): The organism of hematogenous seeding and of post-influenza necrotic pneumonia. Cavitary S. aureus pneumonia complicating influenza has very high mortality. Community-acquired MRSA (USA300 PVL-positive strains) is particularly necrotizing.
• Pseudomonas aeruginosa: Predominantly a cause of nosocomial (hospital-acquired) or healthcare-associated lung abscess, particularly in patients with structural lung disease (bronchiectasis, cystic fibrosis), prolonged ventilator support, or prior antibiotic exposure.
• Streptococcus milleri group (S. anginosus, S. intermedius, S. constellatus): These facultatively anaerobic streptococci are well recognized for their propensity to form abscesses in multiple body compartments. They are consistently underappreciated as a cause of lung abscess.

Pathophysiology and Location

The anatomical location of the abscess provides an important diagnostic clue and reflects the mechanism of aspiration. When aspiration occurs in a recumbent patient, aspirated material flows by gravity into the most dependent lung segments. Understanding which segments are dependent in which body positions determines the classic locations of aspiration-related lung abscess.

Dependent Segment Distribution

• Supine position (most common): The superior segment of the right lower lobe and the posterior segment of the right upper lobe are most dependent — aspirated material flows into these segments preferentially. The right lung is more commonly affected than the left because the right main bronchus is wider, shorter, and more vertically oriented, directing aspirated material more directly into the right lung.
• Right lateral decubitus: The right lower lobe lateral basal segment.
• Upright: The basal segments of both lower lobes.

Aspiration of infected material initiates a sequence: pneumonitis → consolidation → central necrosis → cavitation as the destructive enzymes of bacteria and neutrophils break down lung parenchyma. The thick fibrous wall that forms around the necrotic core is the body's attempt to contain the infection. When the necrotic cavity communicates with an airway, an air-fluid level becomes visible on imaging — this is the hallmark radiographic finding. The contents are then partially expectorated, producing the characteristic foul-smelling, putrid sputum that is almost pathognomonic of anaerobic lung abscess.

Distinguishing Abscess from Empyema

On imaging, a lung abscess and an empyema (pus in the pleural space) can appear similar — both show fluid-containing cavities with air-fluid levels. The distinction is critical because empyema requires pleural drainage while abscess is managed primarily with antibiotics. Key distinguishing features on CT chest:

• Lung abscess: Round or oval shape; forms an acute angle with the chest wall; air-fluid level appears the same length on frontal and lateral views; the surrounding lung shows consolidation or infiltrate.
• Empyema: Lenticular (lens-shaped) or elliptical; forms an obtuse angle with the chest wall (molds to the pleural space); the "split pleura sign" — enhancement of both the visceral and parietal pleural layers around the fluid collection — is characteristic on contrast CT; compression of adjacent lung (rather than consolidation within the lung) is common.

Symptoms and Clinical Presentation

The clinical presentation of lung abscess has a characteristic tempo — insidious, subacute onset over days to weeks — that distinguishes it from acute bacterial pneumonia, which typically presents more abruptly. This subacute course reflects the slow progression from pneumonitis to cavitation and the relative inefficiency of anaerobes as acute pathogens (compared with virulent organisms like Streptococcus pneumoniae).

Common Symptoms

• Cough: Initially dry and non-productive during the consolidation phase; becomes productive once the abscess communicates with an airway. The sputum is the most diagnostically useful symptom: putrid, foul-smelling sputum is nearly pathognomonic of anaerobic lung abscess. The smell results from volatile fatty acids produced during anaerobic metabolism. If a patient or family member reports that the cough produces "horrible smelling" sputum, the diagnosis of anaerobic abscess is effectively confirmed.
• Fever: Present in nearly all patients; often high and spiking, reflecting the infectious nature of the cavity contents. Night sweats are common.
• Malaise and fatigue: Profound, reflecting weeks of ongoing infection and systemic inflammation.
• Weight loss: Significant and disproportionate — patients often lose 5–15 kg over 2–3 weeks. This reflects both the catabolic state of chronic infection and anorexia.
• Pleuritic chest pain: Present when the abscess extends to or involves the parietal pleura. Suggests possible pleural extension or evolving empyema.
• Hemoptysis: Can occur as the abscess erodes into a blood vessel within the cavity wall. Usually small-volume (blood-streaked sputum) but can be massive and life-threatening if a major vessel is eroded.

Physical Examination

Physical examination findings are variable but often include fever, signs of consolidation (dullness, bronchial breathing) over the affected area, and — in chronic or large abscesses — amphoric (hollow, jug-like) breath sounds over the cavity. Signs of poor dentition, alcohol-related liver disease, or neurological disorders that impair swallowing are important contextual clues. Clubbing of the fingers may be seen in prolonged cases (more than 6–8 weeks duration) reflecting chronic suppurative lung disease.

Diagnosis: Imaging and Laboratory

The diagnosis of lung abscess is primarily radiological and requires identifying a thick-walled cavitary lesion with or without an air-fluid level within it. Laboratory findings confirm infection and guide antibiotic selection.

Chest X-ray

Chest X-ray is the initial imaging modality and typically shows a thick-walled cavitary lesion with a central air-fluid level — the presence of both air and fluid within the cavity means the necrotic center has communicated with an airway and some contents have been expectorated. The surrounding parenchyma often shows consolidation. The abscess may be single or, in hematogenous cases, multiple. Early in the disease course (before cavitation occurs), the X-ray may show only dense consolidation indistinguishable from pneumonia.

CT Chest

CT chest with contrast is the definitive imaging modality. Advantages over plain X-ray include:

• Precise localization and size measurement of the abscess cavity
• Detection of multiple abscesses not visible on plain film
• Identification of endobronchial obstruction (tumor, foreign body) causing post-obstructive abscess
• Distinction between lung abscess and empyema (split pleura sign)
• Detection of associated bronchiectasis or underlying structural lung disease
• Evaluation for pleural extension or chest wall involvement

Bronchoscopy

Bronchoscopy is indicated when post-obstructive abscess is suspected (older patients, smokers, absence of typical aspiration risk factors), when the abscess does not respond to antibiotics as expected, or when a tissue diagnosis is required. Bronchoscopy allows direct visualization of the bronchial tree, biopsy of endobronchial lesions, and protected specimen brush sampling for reliable microbiological culture (avoiding oropharyngeal contamination). Bronchoscopy should generally be performed after at least some antibiotic treatment to reduce the risk of flooding the airway with large volumes of purulent material during the procedure.

Sputum and Blood Cultures

Expectorated sputum cultures have limited value for anaerobes due to oropharyngeal contamination but remain useful for detecting aerobes and facultative organisms. Three sets of blood cultures should be obtained in any febrile patient with lung abscess — positive blood cultures establish bacteremia, implicate the causative organism, and raise concern for a hematogenous source (endocarditis, septic thrombophlebitis). Blood cultures are particularly important in suspected S. aureus or Klebsiella abscess.

Laboratory Findings

Laboratory findings reflect a subacute infectious and inflammatory process:

• CBC: Leukocytosis with neutrophilia (often 15,000–25,000/mm³); chronic cases may show anemia of chronic disease (normocytic normochromic)
• Inflammatory markers: ESR markedly elevated (often >100 mm/hr); CRP elevated
• Albumin: Often low, reflecting nutritional depletion and acute-phase response
• Liver function tests: May suggest alcohol-related liver disease as a predisposing factor

Antibiotic Treatment

Antibiotic therapy is the cornerstone of lung abscess management. The choice of antibiotic depends on the mechanism (aspiration vs. non-aspiration) and the likely pathogens. Duration of therapy is prolonged compared to community-acquired pneumonia — typically 3–6 weeks — reflecting the need to penetrate the thick abscess wall and eradicate organisms within the necrotic cavity, where local oxygen tension is low (favoring anaerobes) and blood supply is impaired.

Clindamycin: The Preferred Agent for Anaerobic Aspiration Abscess

Clindamycin has excellent activity against oropharyngeal anaerobes and achieves adequate concentrations in lung tissue. It is the preferred antibiotic for aspiration-related lung abscess based on a landmark randomized trial.

The Levison et al. trial (1983) — often referred to as the LI-C trial — compared clindamycin (600 mg IV q8h) with penicillin G (1 million units IV q4h) in patients with putrid lung abscess or aspiration pneumonia. Clindamycin achieved a significantly higher cure rate (98% vs. 68%) and faster defervescence. The reason for penicillin's inferiority is that many oropharyngeal anaerobes, including Bacteroides species, produce beta-lactamases that inactivate penicillin. Clindamycin is not a beta-lactam and is unaffected by this resistance mechanism. This trial established clindamycin as the gold standard for primary aspiration lung abscess.

Clindamycin Dosing and Step-Down

Typical regimen: clindamycin 600 mg IV every 8 hours until clinically improved (usually 5–7 days), then step down to oral clindamycin 300–450 mg every 6 hours to complete a total course of 3–6 weeks. The total duration depends on clinical and radiological response — treatment should continue until the cavity has resolved or is small and stable on imaging and the patient is clinically well.

Alternative: Amoxicillin-Clavulanate

Amoxicillin-clavulanate (oral: 875/125 mg twice daily; IV: ampicillin-sulbactam) is a reasonable alternative to clindamycin for aspiration abscess. The clavulanate component inhibits beta-lactamases produced by Bacteroides and other anaerobes, restoring activity against these organisms. It is particularly useful in patients who cannot tolerate clindamycin (diarrhea, rash, or concern for C. difficile colitis — a well-recognized risk with clindamycin use).

Special Microbiological Situations

• Klebsiella pneumoniae abscess: Third-generation cephalosporin (ceftriaxone) or a fluoroquinolone (levofloxacin); adjust based on susceptibilities. ESBL-producing Klebsiella requires carbapenem.
• MRSA lung abscess: Vancomycin IV (preferred for necrotizing pneumonia due to higher tissue concentrations) or linezolid. Clindamycin may be used for susceptible strains but inducible resistance (D-zone test positive) is a concern.
• Pseudomonas abscess: Antipseudomonal beta-lactam (piperacillin-tazobactam, ceftazidime, cefepime, or a carbapenem) based on susceptibilities. Often requires prolonged IV therapy.
• Immunocompromised host: Broaden empiric coverage to include fungi (Aspergillus) and Nocardia depending on the degree and type of immunosuppression. BAL or CT-guided biopsy for definitive diagnosis before starting therapy is more important in this population.

Monitoring Response

Response to antibiotics in lung abscess is slower than in uncomplicated pneumonia. Expect fever to resolve over 3–10 days and the cavity to shrink gradually on imaging over weeks. Failure to improve after 7–10 days of appropriate antibiotics should prompt reassessment: Is the organism covered? Is there an obstructing lesion? Is drainage needed? Is the patient actually taking and absorbing the antibiotics?

Drainage and Surgical Intervention

Most primary lung abscesses drain spontaneously through the bronchial tree as the cavity communicates with an airway and contents are expectorated. The approximately 75–90% medical cure rate for primary aspiration abscess means that many patients never require any invasive drainage procedure. The challenge is identifying the 10–25% who will fail medical therapy and need intervention — ideally before they deteriorate significantly.

Indications for Drainage

• Failure to improve after 7–14 days of appropriate antibiotics
• Abscess size >6 cm (large abscesses have lower rates of spontaneous drainage)
• Immunocompromised patient (impaired natural drainage mechanisms)
• Tension empyema or bronchopleural fistula complicating the abscess

Percutaneous CT-Guided Drainage

Image-guided percutaneous drainage (CT or ultrasound) has emerged as the preferred invasive approach for abscesses that fail medical management and are accessible without traversing major airways or vessels. A drainage catheter is placed under CT guidance directly into the abscess cavity through the chest wall. Success rates are high (80–90% in selected series), and the procedure avoids the risks of general anesthesia and surgery. The main concern is the risk of bronchopleural fistula if the catheter traverses normal lung parenchyma — this risk is minimized by choosing a percutaneous route directly through consolidated lung rather than aerated lung.

Bronchoscopic Drainage

In select cases, bronchoscopic drainage using a catheter advanced through the bronchus directly into the abscess cavity can provide therapeutic benefit. This approach is most applicable when the abscess communicates with an airway (visible air-fluid level) and the patient cannot tolerate percutaneous drainage.

Surgical Resection

Surgery — typically pneumonectomy or lobectomy via VATS or open thoracotomy — is reserved for the minority of cases that fail all other measures. Indications include:

• Massive hemoptysis from abscess erosion into a major vessel (surgical emergency)
• Failure of medical therapy and percutaneous drainage
• Suspicion of underlying malignancy requiring resection for diagnosis and treatment
• Bronchopleural fistula not amenable to conservative management

Surgery carries significant morbidity in this patient population (often debilitated, with poor nutritional status and cardiopulmonary reserve), so it is reserved for clear indications after medical management has been maximized.

Outcomes and Complications

The prognosis of lung abscess depends primarily on the mechanism, the causative organism, the patient's immune status, and whether an underlying obstructing lesion is present.

Primary Aspiration Abscess

With clindamycin or amoxicillin-clavulanate, 75–90% of primary aspiration abscesses resolve completely. Clinical improvement (defervescence, reduced sputum) typically precedes radiological improvement by weeks — cavities can persist for months on imaging even after clinical cure. A residual thin-walled cyst after a lung abscess does not indicate treatment failure.

Secondary Lung Abscess

Secondary abscesses have worse outcomes because the underlying cause must also be addressed. Post-obstructive abscesses require treatment of the obstructing lesion (resection of lung cancer, retrieval of foreign body). Hematogenous abscesses require treatment of the source (endocarditis, septic thrombophlebitis) with prolonged IV antibiotics.

Major Complications

• Pleural empyema: Extension of the abscess into the pleural space creates an empyema, which requires separate pleural drainage. Empyema complicating lung abscess is associated with significantly higher mortality and prolonged hospitalization.
• Bronchopleural fistula: Communication between the bronchial tree and the pleural space through the abscess cavity. Presents with pneumothorax plus an air-fluid level in the pleural space. Requires chest tube drainage and often surgery.
• Massive hemoptysis: Erosion of the abscess into a pulmonary artery branch. Life-threatening, requires immediate bronchoscopic or angiographic intervention (bronchial artery embolization) or emergency surgery.
• Septic emboli: Particularly in hematogenous abscesses — spread of infection to brain, kidneys, or other organs.

Mortality

Modern mortality rates for primary aspiration lung abscess are low (under 5%) with appropriate antibiotic therapy. Mortality is higher for secondary abscesses, particularly those due to S. aureus (especially post-influenza necrotizing pneumonia), immunocompromised hosts, and cases complicated by massive hemoptysis or empyema. Abscess in the context of underlying lung cancer carries the prognosis of the cancer rather than the abscess.

References & Research

Key Research Papers

1. Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med. 1983;98(4):466-471. PMID 6340731
2. Marra A. Lung abscess — an update on epidemiology, diagnosis and treatment. Semin Respir Crit Care Med. 2022;43(2):228-241. PMID 35276765
3. Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019;380(7):651-663. PMID 30763196
4. Hammond JMJ, Lyddell C, Potgieter PD, Odell J. Severe pneumococcal pneumonia complicated by massive pulmonary gangrene. Chest. 1993;104(5):1610-1612. PMID 8222828
5. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin Infect Dis. 2005;40(7):915-922. PMID 15824980
6. Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y. Etiology and outcome of community-acquired lung abscess. Respiration. 2010;80(2):98-105. PMID 19786734
7. Kuhajda I, Zarogoulidis K, Tsirgogianni K, et al. Lung abscess — etiology, diagnostic and treatment options. Ann Transl Med. 2015;3(13):183. PMID 26366402
8. Moreira JS, Camargo JJ, Felicetti JC, Goldenfus SA, Moreira AL, Pereira PO. Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004. J Bras Pneumol. 2006;32(2):136-143. PMID 17273574
9. Wali SO, Shugaeri A, Samman YS, Abdelaziz M. Percutaneous drainage of pyogenic lung abscess. Scand J Infect Dis. 2002;34(9):673-679. PMID 12374563
10. Mori T, Ebe T, Takahashi M, Isonuma H, Ikemoto H, Oguri T. Lung abscess: analysis of 66 cases from 1979 to 1991. Intern Med. 1993;32(4):278-284. PMID 8329983
11. Mansharamani NG, Koziel H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med. 2003;9(3):181-185. PMID 12682566
12. Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis. 1979;119(1):19-23. PMID 420457

Back to Table of Contents

Research Papers

The following PubMed topic searches retrieve current peer-reviewed literature on Lung Abscess. Each link opens a live PubMed query.

1. Lung abscess clindamycin anaerobic treatment
2. Aspiration pneumonia lung abscess
3. Klebsiella pneumoniae lung abscess
4. MRSA necrotizing pneumonia cavitation
5. Percutaneous drainage lung abscess
6. Lung abscess bronchoscopy drainage
7. Cavitary pneumonia differential diagnosis
8. Lung abscess empyema complication
9. Pulmonary abscess immunocompromised host
10. Oropharyngeal anaerobes aspiration infection

Back to Table of Contents

Connections

• Pneumonia
• Pleural Effusion
• Pulmonary Fibrosis
• Hypersensitivity Pneumonitis
• Lung Cancer
• Spontaneous Pneumothorax
• Pulmonology
• Sepsis

Back to Table of Contents

Featured Videos